BRPI1008899A2 - derivados 3,3´-espiroindolinona como agentes anticâncer - Google Patents

derivados 3,3´-espiroindolinona como agentes anticâncer

Info

Publication number
BRPI1008899A2
BRPI1008899A2 BRPI1008899A BRPI1008899A BRPI1008899A2 BR PI1008899 A2 BRPI1008899 A2 BR PI1008899A2 BR PI1008899 A BRPI1008899 A BR PI1008899A BR PI1008899 A BRPI1008899 A BR PI1008899A BR PI1008899 A2 BRPI1008899 A2 BR PI1008899A2
Authority
BR
Brazil
Prior art keywords
anticancer agents
spiroindolinone derivatives
spiroindolinone
derivatives
anticancer
Prior art date
Application number
BRPI1008899A
Other languages
English (en)
Inventor
Zhang Jing
Zhang Zhuming
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI1008899A2 publication Critical patent/BRPI1008899A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BRPI1008899A 2009-02-17 2010-02-12 derivados 3,3´-espiroindolinona como agentes anticâncer BRPI1008899A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15308909P 2009-02-17 2009-02-17
PCT/EP2010/051757 WO2010094622A1 (en) 2009-02-17 2010-02-12 3, 3' -spiroindolinone derivatives as anticancer agents

Publications (1)

Publication Number Publication Date
BRPI1008899A2 true BRPI1008899A2 (pt) 2018-03-13

Family

ID=42062321

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1008899A BRPI1008899A2 (pt) 2009-02-17 2010-02-12 derivados 3,3´-espiroindolinona como agentes anticâncer

Country Status (12)

Country Link
US (1) US8217051B2 (pt)
EP (1) EP2398801A1 (pt)
JP (1) JP2012517976A (pt)
KR (1) KR20110104568A (pt)
CN (1) CN102356082A (pt)
AU (1) AU2010215554A1 (pt)
BR (1) BRPI1008899A2 (pt)
CA (1) CA2751767A1 (pt)
IL (1) IL213920A0 (pt)
MX (1) MX2011008176A (pt)
SG (1) SG173629A1 (pt)
WO (1) WO2010094622A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2939778C (en) 2007-01-31 2019-01-29 Dana-Farber Cancer Institute, Inc. Stabilized p53 peptides and uses thereof
CA2682174C (en) 2007-03-28 2021-04-06 President And Fellows Of Harvard College Stitched polypeptides
KR20130099938A (ko) 2010-08-13 2013-09-06 에일러론 테라퓨틱스 인코포레이티드 펩티도미메틱 거대고리
DK2684880T3 (en) 2011-03-10 2018-05-22 Daiichi Sankyo Co Ltd DISPIROPYRROLIDINE DERIVATIVES
CN104039342A (zh) 2011-10-18 2014-09-10 爱勒让治疗公司 拟肽大环化合物
NZ627528A (en) 2012-02-15 2016-05-27 Aileron Therapeutics Inc Peptidomimetic macrocycles
HK1205454A1 (en) 2012-02-15 2015-12-18 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
TWI586668B (zh) 2012-09-06 2017-06-11 第一三共股份有限公司 二螺吡咯啶衍生物之結晶
SG11201503052RA (en) 2012-11-01 2015-05-28 Aileron Therapeutics Inc Disubstituted amino acids and methods of preparation and use thereof
MX2017003797A (es) 2014-09-24 2017-06-15 Aileron Therapeutics Inc Macrociclos peptidomimeticos y usos de los mismos.
MX389354B (es) 2014-09-24 2025-03-20 Aileron Therapeutics Inc Macrociclos peptidomimeticos y formulaciones de los mismos.
KR102595395B1 (ko) 2015-02-20 2023-10-27 다이이찌 산쿄 가부시키가이샤 암의 병용 치료법
WO2016154058A1 (en) 2015-03-20 2016-09-29 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
HK1251165A1 (en) 2015-04-13 2019-01-25 Daiichi Sankyo Company, Limited Treatment method combining mdm2 inhibitor and btk inhibitor
JP2018528217A (ja) 2015-09-10 2018-09-27 エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． Ｍｃｌ−１のモジュレーターとしてのペプチド模倣大環状分子
CN118436801A (zh) 2016-05-20 2024-08-06 豪夫迈·罗氏有限公司 Protac抗体缀合物及其使用方法
TW201818934A (zh) 2016-10-17 2018-06-01 日商第一三共股份有限公司 Ｍｄｍ２抑制劑與ｄｎａ甲基轉移酶抑制劑之倂用治療法
CN115772171A (zh) * 2021-09-09 2023-03-10 沈阳药科大学 一价金催化的螺[吲哚啉-3,3’-哌啶]骨架的合成方法
WO2023056069A1 (en) 2021-09-30 2023-04-06 Angiex, Inc. Degrader-antibody conjugates and methods of using same
WO2024240858A1 (en) 2023-05-23 2024-11-28 Valerio Therapeutics Protac molecules directed against dna damage repair system and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0153818B1 (en) 1984-02-07 1989-03-15 Pfizer Inc. 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
DE3714473A1 (de) 1987-04-30 1988-11-10 Basf Ag Kontinuierliches verfahren zur epimerisierung von zuckern, insbesondere von d-arabinose zu d-ribose
EP0947511A1 (en) 1998-03-30 1999-10-06 F. Hoffmann-La Roche Ag Derivatives of phenoxy acetic acid and of phenoxymethyl tetrazole having antitumor activity
WO1999065494A1 (en) * 1998-06-15 1999-12-23 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
CZ2002203A3 (cs) 1999-07-21 2002-08-14 Astrazeneca Ab Spirooxindolové deriváty
EA019566B1 (ru) 2005-02-22 2014-04-30 Дзе Риджентс Оф Дзе Юниверсити Оф Мичиган Низкомолекулярные ингибиторы mdm2
US7495007B2 (en) 2006-03-13 2009-02-24 Hoffmann-La Roche Inc. Spiroindolinone derivatives
US20070213341A1 (en) 2006-03-13 2007-09-13 Li Chen Spiroindolinone derivatives
AU2007224452A1 (en) 2006-03-13 2007-09-20 F. Hoffmann-La Roche Ag Spiroindolinone derivatives
CN101595107A (zh) 2006-06-30 2009-12-02 先灵公司 能提高p53活性的有取代哌啶及其用途
WO2008060789A2 (en) * 2006-10-12 2008-05-22 Xenon Pharmaceuticals Inc. Use of spiro-oxindole compounds as therapeutic agents
US7638548B2 (en) 2006-11-09 2009-12-29 Hoffmann-La Roche Inc. Spiroindolinone derivatives
WO2008080822A1 (en) 2006-12-29 2008-07-10 F. Hoffmann-La Roche Ag Epimerization methodologies for recovering stereo isomers in high yield and purity
US7553833B2 (en) * 2007-05-17 2009-06-30 Hoffmann-La Roche Inc. 3,3-spiroindolinone derivatives
US7834179B2 (en) * 2007-05-23 2010-11-16 Hoffmann-La Roche Inc. Spiroindolinone derivatives
US7776875B2 (en) 2007-12-19 2010-08-17 Hoffman-La Roche Inc. Spiroindolinone derivatives

Also Published As

Publication number Publication date
KR20110104568A (ko) 2011-09-22
CN102356082A (zh) 2012-02-15
IL213920A0 (en) 2011-07-31
AU2010215554A1 (en) 2011-07-28
JP2012517976A (ja) 2012-08-09
SG173629A1 (en) 2011-09-29
CA2751767A1 (en) 2010-08-26
MX2011008176A (es) 2011-08-17
WO2010094622A1 (en) 2010-08-26
US8217051B2 (en) 2012-07-10
EP2398801A1 (en) 2011-12-28
US20100210674A1 (en) 2010-08-19

Similar Documents

Publication Publication Date Title
HUS2300018I1 (hu) Rákellenes hatású kinoli-8-szulfonamid-származékok
BRPI1008899A2 (pt) derivados 3,3´-espiroindolinona como agentes anticâncer
BRPI0919295A2 (pt) 1h-benzimidazol-5-carboxamidas como agentes anti-inflamatórios.
BR112013003245A2 (pt) derivados de heteroarilpiperidina e -piperazina como fungicidas
SMT201500053B (it) 2-Amminobenzimidazol-5-carbossammidi come agenti nati-infiammatori
BRPI0922845A2 (pt) pirazol-4-n-alcoxicarboxamidas como microbiocidas
BRPI1008939A2 (pt) 2-mercaptoquinolina-3-carboxamidas substituídas como moduladores de kncq2/3.
BRPI1006113A2 (pt) "derivado de piridina".
ZA201205788B (en) 1,2,4-triazine-4-amine derivatives
BRPI1014077A2 (pt) Derivados de tiazolilperidina como fungicidas
LT2616102T (lt) Provaistas, apimantis eksendino-linkerio konjugatą
ATE536355T1 (de) 3,3-spiroindolinionderivate als antikrebsmittel
BRPI0810462A2 (pt) Derivados de quinolina-carboxamida como antagonistas de p2y12
ATE555107T1 (de) 2-aza-bicyclo-ä2,2,1-üheptan-derivate
UY33125A (es) Diaza-espiro-[5,5]-undecanos
BRPI0817562A2 (pt) derivados de n-hidroxilsulfonamida como novos doadores de niltroxil fisiologicamente úteis
BRPI1011460A2 (pt) Composição desinfetante.
BRPI1012155A2 (pt) cateter de segurança.
ITUD20110032A1 (it) "macchina da fienagione"
SI2513119T1 (sl) 3,4,4a,10b-tetrahidro-1H-tiopirano-(4,3-c)izokinolinski derivati
DK2442870T3 (da) Pyrazinooxazepin-derivater.
BRPI1016192A2 (pt) derivados de soxazol.
BRPI1011416A2 (pt) derivados de antraquinova novos
ES2617187T8 (es) Derivados de sal de benzoquinolizinio como agentes anticancerosos
PL2623499T3 (pl) Pochodne 1,2,4-triazolonu

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A, 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]